[HTML][HTML] The role of inflammation in diabetes: current concepts and future perspectives
S Tsalamandris, AS Antonopoulos… - European cardiology …, 2019 - ncbi.nlm.nih.gov
Diabetes is a complex metabolic disorder affecting the glucose status of the human body.
Chronic hyperglycaemia related to diabetes is associated with end organ failure. The clinical …
Chronic hyperglycaemia related to diabetes is associated with end organ failure. The clinical …
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Despite its position as the first-line drug for treatment of type 2 diabetes mellitus, the
mechanisms underlying the plasma glucose level-lowering effects of metformin (1, 1 …
mechanisms underlying the plasma glucose level-lowering effects of metformin (1, 1 …
Master regulator activating transcription factor 3 (ATF3) in metabolic homeostasis and cancer
HC Ku, CF Cheng - Frontiers in Endocrinology, 2020 - frontiersin.org
Activating transcription factor 3 (ATF3) is a stress-induced transcription factor that plays vital
roles in modulating metabolism, immunity, and oncogenesis. ATF3 acts as a hub of the …
roles in modulating metabolism, immunity, and oncogenesis. ATF3 acts as a hub of the …
Metformin, macrophage dysfunction and atherosclerosis
Metformin is one of the most widely prescribed hypoglycemic drugs and has the potential to
treat many diseases. More and more evidence shows that metformin can regulate the …
treat many diseases. More and more evidence shows that metformin can regulate the …
Metformin improves obesity-associated inflammation by altering macrophages polarization
Y Jing, F Wu, D Li, L Yang, Q Li, R Li - Molecular and cellular …, 2018 - Elsevier
Obesity is reported to be a chronic low-grade inflammatory state. Adipose tissue
macrophages play a key role in obesity-related inflammation. Metformin, the most widely …
macrophages play a key role in obesity-related inflammation. Metformin, the most widely …
Metformin as an anti-inflammatory agent: a short review
R Kristófi, JW Eriksson - Journal of Endocrinology, 2021 - joe.bioscientifica.com
Metformin is a biguanide drug widely used as the initial treatment of type 2 diabetes. Despite
its widespread use, its precise mechanisms of action remain incompletely characterised. Its …
its widespread use, its precise mechanisms of action remain incompletely characterised. Its …
[HTML][HTML] Metformin induces the M2 macrophage polarization to accelerate the wound healing via regulating AMPK/mTOR/NLRP3 inflammasome singling pathway
L Qing, J Fu, P Wu, Z Zhou, F Yu… - American journal of …, 2019 - ncbi.nlm.nih.gov
Background: Skin wound healing is a challenging problem, especially in aging or diabetic
patients, which becomes more difficult to heal, and easily results in considerable public …
patients, which becomes more difficult to heal, and easily results in considerable public …
Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management
With an increasing global burden of coronary artery disease (CAD), early detection and
timely management of risk factors are crucial to reduce morbidity and mortality in such …
timely management of risk factors are crucial to reduce morbidity and mortality in such …
Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data
Background Metformin, the eldest and most widely used glucose lowering drug, is likely to
be effective also on cardiac and vascular disease prevention. Nonetheless, uncertainty still …
be effective also on cardiac and vascular disease prevention. Nonetheless, uncertainty still …
Metformin and autoimmunity: a “new deal” of an old drug
Metformin (dimethyl biguanide) is a synthetic derivative of guanidine, isolated from the
extracts of Galega officinalis, a plant with a prominent antidiabetic effect. Since its discovery …
extracts of Galega officinalis, a plant with a prominent antidiabetic effect. Since its discovery …